Teva Pharmaceutical Industries Ltd. http://www.alacrastore.com/company-snapshot/Teva_Pharmaceutical_Industries_Ltd-1016520 Saturday, October 11, 2008 3:14:37 AM 1016520 Teva Pharmaceutical Industries Ltd. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T1982762ccbn/T1982762norm... - UBS - AnalystGood afternoon, everyone. Thank you all for being here. It is my pleasure to introduce Eyal Desheh, Chief Financial Officer of TEVA Pharmaceuticals. Just a quick reminder, we will have a Breakout Session, it is going to be a floor below where we are right now and that's going to be in the Broadway Conference Room. Thank you. ... 9/24/2008 6:05:00 PMTeva Pharmaceutical54.0000FinalTeva Pharmaceutical at UBS Global Life Sciences Conference TranscriptTEVA3:00pm ETTranscriptT1982762Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-28270392newstex/BW-0001-28270392xml Sep. ##, #### (Business Wire) -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Kowa Company, Ltd. today announced that they have signed a definitive agreement to establish a leading generic pharmaceutical company in Japan....090000000901500004000000040020000400200604010000040100010401600004016005040060000400600507000000070140000701401207003000070030011300000013010000130100050200000002002000020020049/24/2008 2:18:51 AM18000000180200001802200018016000190000001900100019002000190020041900200919002013Business WireBW-0001-28270392TEVA PHARMACEUTICAL INDUSTRIES LTDTEVANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-28266153newstex/PRN-0005-28266153xml WILMINGTON, Del., Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- AstraZeneca today announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in...04000000040020000400200604006000040060050700000007014000070140120700300007003001020000000200200002002008020020049/23/2008 7:18:51 PM18000000180180001900000019001000PR Newswire USPRN-0005-28266153ASTRAZENECA PLCTEVA PHARMACEUTICAL INDUSTRIES LTDAZNTEVANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-28067874newstex/BW-0001-28067874xml Sep. ##, #### (Business Wire) -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced presentations of several new studies at the World Congress on Treatment and Research in Multiple Sclerosis in Montreal. New data will...07000000070050000700100004000000040020000400200607014000070140120701400607003000070030011300000013010000130100050200000002002000020020049/15/2008 9:26:54 AM1800000018020000180160001900000019001000190020001900201319002007Business WireBW-0001-28067874TEVA PHARMACEUTICAL INDUSTRIES LTDTEVANewsNewstexCHILE - Laboratorio Chile SA, a unit of Teva Pharmaceutical Industries Ltd's Ivax Corp subsidiary, acquired Maam Co SA, a manufacturer and wholesaler of cosmetics.9/13/2008 11:43:51 AM50540H55172F88162455172FLaboratorio Chile SAMaam Co SATeva Pharmaceutical Industries LtdMaam Co SAhttp://www.alacrastore.com/storecontent/Thomson_M%26A/Laboratorio_Chile_SA_acquires_Maam_Co_SA-2011588040sdc/20115880402011588040Copyright © 2008, Thomson Financial, All Rights ReservedDrugsChilePharmaceutical preparations2834FFForeignSubsidiary2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5122:Drugs, drug proprietaries, and druggists' sundries2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substancesSoaps, Cosmetics, and Personal-Care ProductsChilePerfumes, cosmetics, and other toilet preparations2844FFForeignPrivate279349002Mnfr prescription pharmMnfr,whl cosmeticsUnspecifiedAssets1039983001Sep 13 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.00000Laboratorio Chile SA,headquartered in Santiago,Chile, manufactures andwholesales pharmaceuticals.The company was founded in1896.Laboratorio Chile SA, headquartered in Santiago, Chile,manufactures and wholesales pharmaceuticals. The company wasfounded in 1896.Laboratorio Chile SA, headquartered in Santiago, Chile, manufactures and wholesales pharmaceuticals. The company was founded in 1896.1.000002.000003.000004.000005.00000Maam Co SA, headquartered inSantiago, Chile, manufacturesand wholesales cosmetics,including lotions and creamsfor pregnant women.Maam Co SA, headquartered in Santiago, Chile, manufacturesand wholesales cosmetics, including lotions and creams forpregnant women.Maam Co SA, headquartered in Santiago, Chile, manufactures and wholesales cosmetics, including lotions and creams for pregnant women.0.000000.000000.000000.00000Y10 Sep 08Wed, 10 Sep 2008 00:00:00 ESTDate Announced: 09/10/200810 Sep 08Date Effective: 09/10/200810 Sep 08Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.00000100.00000100.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.00000CHILE - Laboratorio Chile SA,a unit of Teva PharmaceuticalIndustries Ltd's Ivax Corpsubsidiary, acquired Maam CoSA, a manufacturer andwholesaler of cosmetics.CHILE - Laboratorio Chile SA, a unit of Teva Pharmaceutical Industries Ltd's Ivax Corp subsidiary, acquired Maam Co SA, a manufacturer and wholesaler of cosmetics.CHILE - Laboratorio Chile SA, a unit of Teva Pharmaceutical Industries Ltd's Ivax Corpsubsidiary, acquired Maam Co SA, a manufacturer and wholesaler of cosmetics.CHILE - Laboratorio Chile SA, a unit of Teva Pharmaceutical Industries Ltd's Ivax Corp subsidiary, acquired Maam Co SA, a manufacturer and wholesaler of cosmetics.CHILE - Laboratorio Chile SA, a unit of Teva Pharmaceutical Industries Ltd's Ivax Corp subsidiary, acquired Maam Co SA, a manufacturerand wholesaler of cosmetics.Completed0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Completed-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002844:Perfumes, cosmetics, and other toilet preparations5122:Drugs, drug proprietaries, and druggists' sundries5940001NasdaqIsrael2834ForeignPublicTEVA2844:Perfumes, cosmetics, and other toilet preparations5122:Drugs, drug proprietaries, and druggists' sundries1039983001Chile2844ForeignPrivate0.000000.000000.000000.00000Deal InformationTF Mergers & AcquisitionsUS - An investor group, comprised of Paul Kennedy and Patrice Debregeas, acquired a ##% interest in, or ##.### mil common shares in IVAX Diagnostics Inc, a manufacturer of diagnostic test kits, reagents, and scientific instruments, from Teva Pharmaceutical Industries Ltd, for $#.# per share, or a total value of $##.### mil.9/4/2008 9:54:30 AM46145M45070W46145M881624Investor GroupIVAX Diagnostics IncInvestor GroupTeva Pharmaceutical Industries Ltdhttp://www.alacrastore.com/storecontent/Thomson_M%26A/Investor_Group_acquires_IVAX_Diagnostics_Inc_from_IVAX_Corp-2009120020sdc/20091200202009120020Copyright © 2008, Thomson Financial, All Rights ReservedInvestment & Commodity Firms,Dealers,ExchangesFranceInvestors, nec6799FFForeignPrivate6799:Investors, nec6799:Investors, necAmericanDrugsUnited StatesPharmaceutical preparations2834FLFloridaPublicIVD9920001Investor groupMnfr prescription pharmCashCash OnlyCommon Stock614576003Sep 4 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.00000Investor groupInvestor groupInvestor group1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.00000IVAX Diagnostics Inc, locatedin Miami, Florida,manufactures diagnostic testkits, reagents, and scientificinstruments, through its threesubsidiaries; DiamedixCorporation, Delta BiologicalsS.r.l. and ImmunoVision Inc.The company was founded inMarch 14, 2001.IVAX Diagnostics Inc, located in Miami, Florida,manufactures diagnostic test kits, reagents, and scientificinstruments, through its three subsidiaries; DiamedixCorporation, Delta Biologicals S.r.l. and ImmunoVision Inc.The company was founded in March 14, 2001.IVAX Diagnostics Inc, located in Miami, Florida, manufactures diagnostic test kits, reagents, and scientific instruments, through its three subsidiaries; Diamedix Corporation, Delta Biologicals S.r.l. and ImmunoVision Inc. The company was founded in March 14, 2001.0.000000.000000.0000027.65000YU.S. Dollar02 Sep 08Tue, 02 Sep 2008 00:00:00 ESTDate Announced: 09/02/200802 Sep 08Date Effective: 09/02/200802 Sep 08Acq. Maj. Int.Friendly0.000000.000000.000000.000000.000000.70000Price/Share0.0000013.936 U.S. Dollar13.9360019.3550013.936 U.S. Dollar13.9360072.0000072.000000.700000.7000013.9360013.936 U.S. Dollar1.00000N7.820000.000000.000000.000000.000000.0000013.9360013.936000.000000.000000.000000.000000.000000.000000.0000072.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.00000US - An investor group,comprised of Paul Kennedy andPatrice Debregeas, acquired a72% interest in, or 19.908 milcommon shares in IVAXDiagnostics Inc, amanufacturer of diagnostictest kits, reagents, andscientific instruments, fromTeva Pharmaceutical IndustriesLtd, for $0.7 per share, or atotal value of $13.936 mil.US - An investor group, comprised of Paul Kennedy and Patrice Debregeas, acquired a 72% interest in, or 19.908 mil common shares in IVAX Diagnostics Inc, a manufacturer of diagnostic test kits, reagents, and scientific instruments, from Teva Pharmaceutical Industries Ltd, for $0.7 per share, or a total value of $13.936 mil.US - An investor group, comprised of Paul Kennedy and Patrice Debregeas, acquired a 72%interest in, or 19.908 mil common shares in IVAX Diagnostics Inc, a manufacturer ofdiagnostic test kits, reagents, and scientific instruments, from Teva PharmaceuticalIndustries Ltd, for $0.7 per share, or a total value of $13.936 mil.US - An investor group, comprised of Paul Kennedy and Patrice Debregeas, acquired a 72% interest in, or 19.908 mil common shares in IVAX Diagnostics Inc, a manufacturer of diagnostic test kits,reagents, and scientific instruments, from Teva Pharmaceutical Industries Ltd, for $0.7 per share, or a total value of $13.936 mil.US - An investor group, comprised of Paul Kennedy and Patrice Debregeas, acquired a 72% interest in, or 19.908 mil common shares in IVAXDiagnostics Inc, a manufacturer of diagnostic test kits, reagents, and scientific instruments, from Teva Pharmaceutical Industries Ltd,for $0.7 per share, or a total value of $13.936 mil.Completed0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Completed-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002834:Pharmaceutical preparations2835:In vitro and in vivo diagnostic substances3826:Laboratory analytical instruments9920001Unknown6799ForeignPrivate2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5940001NasdaqIsrael2834ForeignPublicTEVA13.9360013.9360013.936007.82000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27867127newstex/PRN-0005-27867127xml JERUSALEM and MONTVALE, N.J., Sep. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that, as expected, each party has...0400000004002000040020060401600004016005040160030700000007014000070140120700300007003001130000001301000013010005020000000200200002002006020020049/3/2008 3:17:25 PM180000001801600018020000180250001900000019001000PR Newswire USPRN-0005-27867127BARR PHARMACEUTICALS INCTEVA PHARMACEUTICAL INDUSTRIES LTDBRLTEVANewsNewstexhttp://www.alacrastore.com/storecontent/bir/516792bir/516792normTeva Pharmaceutical Industries Ltd.Ivaco Industries Inc.DVM Pharmaceuticals Inc.Wakefield Pharmaceuticals Inc.Advanced Tobacco Products Inc.IVAX Laboratories Inc.IVAXinteractive Inc.IsraelManufacturing: Manufacture and distribution of generic and ethical drugs, fine chemicals for the pharmaceutical industry, hospital supplies, veterinary products, active pharmaceutical ingredients28342833512287313254123254114242105417109IKTEVA8/26/2008 6:21:00 AM516792Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27508147newstex/PRN-0005-27508147xml VIENNA, Va., Aug. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- CEL-SCI Corporation (Amex: CVM) announced today that it has entered into an exclusive licensing agreement with Teva Pharmaceutical Industries Ltd. (Teva), a leading...070000000700500004000000040020000400200607001000070010040701400007014008070140060701401207003000070030018/19/2008 11:19:08 AM180000001802200018020000190000001900200019002007PR Newswire USPRN-0005-27508147CEL SCI CORPTEVA PHARMACEUTICAL INDUSTRIES LTDGEERT R KERSTENCVMTEVANewsNewstexGERMANY - Teva Pharmaceutical Industries Ltd of Israel was rumored to be planning to acquire the entire ordinary share capital of STADA Arzneimittel AG, a Bad Vilbel-based manufacturer of pharmaceutical products.8/16/2008 12:38:04 PM88162485234B88162485234BTeva Pharmaceutical Industries LtdSTADA Arzneimittel AGTeva Pharmaceutical Industries LtdSTADA Arzneimittel AGhttp://www.alacrastore.com/storecontent/Thomson_M%26A/Teva_Pharma_Inds_Ltd_is_rumored_to_be_planning_to_acquire_STADA_Arzneimittel_AG-2004643040sdc/20046430402004643040Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqDrugsIsraelPharmaceutical preparations2834FFForeignPublicTEVA2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substancesFrankfurtDrugsGermanyPharmaceutical preparations2834FFForeignPublicSTAG5940001Mnfr prescription pharmMnfr pharm prodNot ApplicableOrdinary Share164522002Aug 16 200824.85300120.64800466.80600454.98200332.71300258.70400173.42400176.213001456.555000.625001.15500355.705002.94800172.67900242.521002537.24400593.290003971.78300EUR31 Dec 071.0000011639.521001.0000056098.68000131381.79400EURO31 Mar 0831 Dec 0731 Dec 0631 Dec 0531 Dec 0431 Dec 031.577001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.0000021.0000022.0000023.0000024.0000025.0000026.0000027.0000028.0000029.0000030.0000031.0000032.0000033.0000034.00000Teva Pharmaceutical IndustriesLtd, headquartered in Tikva,Israel, manufacturesprescription pharmaceuticalsand Active pharmaceuticalingredients. The Groupoperates under two segments:Pharmaceutical and API. UnderPharmaceutical, the Groupinvolves in the development,production, marketing anddistribution of drugs invarious dosages and forms, inmost areas of medicinaltreatment and disposablehospital supplies. Under API,the Group involves in thedevelopment, production,marketing and distribution ofAPI for the pharmaceuticalindustry. The Groupmanufactures solid dosageforms, injectables, liquids,semi-solids and inhalers. Theproducts of the Group includeCopaxone and Azilect. TheGroup operates with 34 dosagepharmaceutical plants in NorthAmerica, Latin America,Europe, Israel and China. Themajority of the Group's salesare in North America andWestern Europe. The companywas founded in 1901.Teva Pharmaceutical Industries Ltd, headquartered in Tikva,Israel, manufactures prescription pharmaceuticals and Activepharmaceutical ingredients. The Group operates under twosegments: Pharmaceutical and API. Under Pharmaceutical, theGroup involves in the development, production, marketing anddistribution of drugs in various dosages and forms, in mostareas of medicinal treatment and disposable hospitalsupplies. Under API, the Group involves in the development,production, marketing and distribution of API for thepharmaceutical industry. The Group manufactures solid dosageforms, injectables, liquids, semi-solids and inhalers. Theproducts of the Group include Copaxone and Azilect. TheGroup operates with 34 dosage pharmaceutical plants in NorthAmerica, Latin America, Europe, Israel and China. Themajority of the Group's sales are in North America andWestern Europe. The company was founded in 1901.Teva Pharmaceutical Industries Ltd, headquartered in Tikva, Israel, manufactures prescription pharmaceuticals and Active pharmaceutical ingredients. The Group operates under two segments: Pharmaceutical and API. Under Pharmaceutical, the Group involves in the development, production, marketing and distribution of drugs in various dosages and forms, in most areas of medicinal treatment and disposable hospital supplies. Under API, the Group involves in the development, production, marketing and distribution of API for the pharmaceutical industry. The Group manufactures solid dosage forms, injectables, liquids, semi-solids and inhalers. The products of the Group include Copaxone and Azilect. The Group operates with 34 dosage pharmaceutical plants in North America, Latin America, Europe, Israel and China. The majority of the Group's sales are in North America and Western Europe. The company was founded in 1901.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.00000STADA Arzneimittel AG, locatedin Bad Vilbel, Germany,manufactures prescriptionpharmaceuticals intended forfinal consumption, includingbiotech products andantibiotics. The companydevelops, produces anddistributes natural herbalremedies and publishesinformation on all currentpharmaceuticals for medicalpractitioners, pharmacists,hospitals and clinics. It alsomanufactures cosmetics, finechemicals, food additives andsupplements. The company wasfounded in 1895.STADA Arzneimittel AG, located in Bad Vilbel, Germany,manufactures prescription pharmaceuticals intended for finalconsumption, including biotech products and antibiotics. Thecompany develops, produces and distributes natural herbalremedies and publishes information on all currentpharmaceuticals for medical practitioners, pharmacists,hospitals and clinics. It also manufactures cosmetics, finechemicals, food additives and supplements. The company wasfounded in 1895.STADA Arzneimittel AG, located in Bad Vilbel, Germany, manufactures prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics. The company develops, produces and distributes natural herbal remedies and publishes information on all current pharmaceuticals for medical practitioners, pharmacists, hospitals and clinics. It also manufactures cosmetics, fine chemicals, food additives and supplements. The company was founded in 1895.100.000001.000001.0000058.76000Y14 Aug 08Thu, 14 Aug 2008 00:00:00 ESTDate Announced: 08/14/2008Date Effective:MergerNot Appl.100.000001.000001.000000.000001.000001.00000Price/Share1.0000011.0000059.6090011.000000.000000.000001.000001.00000990.2950011.00000N0.000001.00000100.000001.000001.000001.000000.000001.000000.000000.000000.000000.000000.000000.000000.00000100.000000.338000.44300100.000000.913000.062000.000000.000000.0000034493.6460045.7460051.5790073.0650032.6160026.762000.347000.0000036.2230015.399001088.598000.000001.577000.000000.0000042.7650024.422001.000002.000003.000004.000005.000006.000007.000008.00000GERMANY - Teva PharmaceuticalIndustries Ltd of Israel wasrumored to be planning toacquire the entire ordinaryshare capital of STADAArzneimittel AG, a BadVilbel-based manufacturer ofpharmaceutical products.GERMANY - Teva Pharmaceutical Industries Ltd of Israel was rumored to be planning to acquire the entire ordinary share capital of STADA Arzneimittel AG, a Bad Vilbel-based manufacturer of pharmaceutical products.GERMANY - Teva Pharmaceutical Industries Ltd of Israel was rumored to be planning toacquire the entire ordinary share capital of STADA Arzneimittel AG, a Bad Vilbel-basedmanufacturer of pharmaceutical products.GERMANY - Teva Pharmaceutical Industries Ltd of Israel was rumored to be planning to acquire the entire ordinary share capital of STADA Arzneimittel AG, a Bad Vilbel-based manufacturer ofpharmaceutical products.GERMANY - Teva Pharmaceutical Industries Ltd of Israel was rumored to be planning to acquire the entire ordinary share capital of STADAArzneimittel AG, a Bad Vilbel-based manufacturer of pharmaceutical products.Rumor52990.310007971.9090038421.9900089983.4010015.76400296.09500288.59500211.04000164.09600110.00300111.77200923.89300225.624001.800001.700000.970000.910001.015001.870001.000001.000001.000001.000001.000001.00000105.1360091.8330051.5830048.4840043.86900109.53000150.68700145.1580097.5160077.5500072.10700153.831001570.490001245.050001022.05900813.51900745.209001609.374002519.302002531.034002136.820001338.391001010.76500945.43400Status:RumorEUR-999.00000np0.09600-999.00000np24.3080020.2330011.8550023.9590020.487001456.5550037.5170027.914000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5940001NasdaqIsrael2834ForeignPublicTEVA2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances164522002FrankfurtGermany2834ForeignPublicSTAG1.000001.000001.000000.53500Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27385522newstex/PRN-0005-27385522xml HOPKINTON, Mass., Aug. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today reports operational and financial results for the quarter ended June ##, #### and provides further information...070000000700500004000000040020000400200604016000040160180701400007014012070030000700300113000000130100001301000513005000130050020200000002002000020020048/13/2008 5:18:15 PM1800000018004000PR Newswire USPRN-0005-27385522ALSERES PHARMACEUTICALS INC.BRISTOL MYERS SQUIBB COBRISTOL-MYERS SQUIBB COMPANY $2 CONVERTIBLETEVA PHARMACEUTICAL INDUSTRIES LTDPETER G SAVASROBERT L GIPSONALSEBMYBMY PRTEVANewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1899855ccbn/B1899855norm...EPA and FDA clearly communicated no CFC based inhalers may be sold after December ##. www.streetevents.comContact Us ... 7/29/2008 11:06:00 AMTeva Pharmaceutical54.0000EditedTeva Pharmaceutical Q2 2008 Earnings Conference Call SummaryTEVA8:30am ETBriefB1899855Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1899855ccbn/T1899855norm...Greetings and welcome to the Teva Pharmaceutical Industries Limited second quarter #### results conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Elana Holzman. Thank you, Miss Holzman, you may begin. ... 7/29/2008 10:48:00 AMTeva Pharmaceutical54.0000FinalTeva Pharmaceutical Q2 2008 Earnings Conference Call TranscriptTEVA8:30am ETTranscriptT1899855Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/MCOM-0004-26864060newstex/MCOM-0004-26864060xml Jul. ##, #### (M# Communications Ltd. delivered by Newstex) -- The stockholders of Bentley Pharmaceuticals Inc (NYSE: BNT), a specialty pharmaceutical company, said on ## July that they have given their approval for the Agreement and...04000000040160000401600504002000040020060200000002002000020020060700000007014000070140121300000013010000130100057/23/2008 11:19:13 AM1800000018016000M2 EquityBitesMCOM-0004-26864060BENTLEY PHARMACEUTICALS INCTEVA PHARMACEUTICAL INDUSTRIES LTDBNTTEVANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MCOM-0004-26826675newstex/MCOM-0004-26826675xml Jul. ##, #### (M# Communications Ltd. delivered by Newstex) -- Industrial Info Resources (Sugar Land, Texas) declared on ## July that generic company Teva Pharmaceutical Industries Limited (Jerusalem, Israel) has entered into an agreement...04000000040020000400200604016000040160050700000007014000070140121300000013010000130100057/22/2008 5:16:47 AM1800000018016000M2 EquityBitesMCOM-0004-26826675BARR PHARMACEUTICALS INCTEVA PHARMACEUTICAL INDUSTRIES LTDBRLTEVANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26815401newstex/PRN-0005-26815401xml TOKYO and WOODCLIFF LAKE, N.J., Jul. ##, #### (PRNewswire delivered by Newstex) -- With respect to Eisai's patent infringement lawsuit against Teva Pharmaceuticals and Dr. Reddy's Laboratories concerning Aciphex(R) (generic name: rabeprazole...040000000400200004002006040160000401603104006000040060050200000002002000020020080200200407000000070140000701401207003000070030011300000013010000130100057/21/2008 6:21:55 PM1800000018018000180200001900000019001000PR Newswire USPRN-0005-26815401DR REDDYS LABORATORIES LTDTEVA PHARMACEUTICAL INDUSTRIES LTDRDYTEVANewsNewstexhttp://www.alacrastore.com/storecontent/newstex/IPR-0001-26808990newstex/IPR-0001-26808990xml ISRAEL, Jul. ##, #### (Info-Prod Research delivered by Newstex) -- Moody's Investors Service affirmed the Baa#ratings of Teva Pharmaceutical Industries Limited ("Teva"). At the sametime, Moody's placed the ratings of Barr Laboratories,...04000000040020000400200604016000040160057/21/2008 1:17:49 PM1800000018016000Info-Prod ResearchIPR-0001-26808990TEVA PHARMACEUTICAL INDUSTRIES LTDTEVANewsNewstexUS - Teva Pharmaceutical Industries Ltd (TP) definitively agreed to acquire all the outstanding common stock of Barr Pharmaceuticals Inc (BP), a manufacturer, wholesaler and developer of generic and proprietary prescription pharmaceuticals, in a transaction valued at $#.## bil. TP offered #.#### common shares and $##.## in cash per TP share. Based on TP's closing stock price of July ##, the last full trading day prior to the announcement, each BP share was valued at $##.###. The transaction was approved by TP and BP's board of directors and was subject to customary closing conditions and BP shareholder approval. Originally, TP was rumored to be planning to acquire all the outstanding stock of BP.7/19/2008 1:17:02 PM881624068306881624068306Teva Pharmaceutical Industries LtdBarr Pharmaceuticals IncTeva Pharmaceutical Industries LtdBarr Pharmaceuticals Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Teva_Pharma_Inds_Ltd_acquires_Barr_Pharmaceuticals_Inc-1996847020sdc/19968470201996847020Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqDrugsIsraelPharmaceutical preparations2834FFForeignPublicTEVA2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substancesWillkie Farr & GallagherNew YorkDrugsUnited StatesPharmaceutical preparations2834NJNew JerseyPublicBRL5940001Mnfr prescription pharmMnfr,whl pharmAmer. Depy. ReceiptCashCommon StockOption661004Jul 19 200819.01400505.00000642.49700615.06500572.69700420.04700389.84000253.239002053.000000.570000.99500338.986001.40000139.77800223.503002509.20400299.000004845.00000IS31 Dec 070.0000010.373302069.013000.000009971.9660023354.11200Israeli Shekel31 Mar 0831 Dec 0731 Dec 0631 Dec 0531 Dec 0431 Dec 031.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.00000Teva Pharmaceutical IndustriesLtd, headquartered in Tikva,Israel, manufacturesprescription pharmaceuticalsspecializing in thedevelopment of generic andproprietary brandedpharmaceuticals as well asactive pharmaceuticalingredients. The company wasfounded in 1901.Teva Pharmaceutical Industries Ltd, headquartered in Tikva,Israel, manufactures prescription pharmaceuticalsspecializing in the development of generic and proprietarybranded pharmaceuticals as well as active pharmaceuticalingredients. The company was founded in 1901.Teva Pharmaceutical Industries Ltd, headquartered in Tikva, Israel, manufactures prescription pharmaceuticals specializing in the development of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. The company was founded in 1901.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.00000Barr Pharmaceuticals Inc,headquartered in Montvale, NewJersey, manufactures,wholesales and developsgeneric and proprietaryprescription pharmaceuticals,brands include Desogen,Ortho-cept, Alesse, Danocrine,Adderall, Dexedrine, Spansule,Persantine, Prozac, Mircette,Levlite, Provera, Rheumatrex,Aygestin and Coumadin and aholding company. The companywas founded in 1970.Barr Pharmaceuticals Inc, headquartered in Montvale, NewJersey, manufactures, wholesales and develops generic andproprietary prescription pharmaceuticals, brands includeDesogen, Ortho-cept, Alesse, Danocrine, Adderall, Dexedrine,Spansule, Persantine, Prozac, Mircette, Levlite, Provera,Rheumatrex, Aygestin and Coumadin and a holding company. Thecompany was founded in 1970.Barr Pharmaceuticals Inc, headquartered in Montvale, New Jersey, manufactures, wholesales and develops generic and proprietary prescription pharmaceuticals, brands include Desogen, Ortho-cept, Alesse, Danocrine, Adderall, Dexedrine, Spansule, Persantine, Prozac, Mircette, Levlite, Provera, Rheumatrex, Aygestin and Coumadin and a holding company. The company was founded in 1970.0.000000.000000.00000117.01000YU.S. Dollar18 Jul 08Fri, 18 Jul 2008 00:00:00 ESTDate Announced: 07/18/2008Date Effective:MergerFriendly0.000000.000000.000008841.128000.0000065.64700Price/Share0.000008810.21 U.S. Dollar8810.214007304.128008847.21 U.S. Dollar8847.214000.000000.0000065.6470065.647008847.214008847.21 U.S. Dollar1.00000N4407.31100200.000000.000000.00000200.000001500.000007310.214008810.2140011.3680013.7610026.0810063.251003.523002.192000.00000100.0000013.7700026.099004.2430063.295003.5260031.1320063.030003.5110036686.9160046.8200044.0600041.6800021.0070024.838000.426008841.12800-19.66800-5.171001743.000004504.081002085.0000024.2330021.70700-22.73400-6.448001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.0000021.0000022.0000023.0000024.0000025.0000026.00000US - Teva PharmaceuticalIndustries Ltd (TP)definitively agreed to acquireall the outstanding commonstock of Barr PharmaceuticalsInc (BP), a manufacturer,wholesaler and developer ofgeneric and proprietaryprescription pharmaceuticals,in a transaction valued at$8.81 bil. TP offered 0.6272common shares and $39.90 incash per TP share. Based onTP's closing stock price ofJuly 17, the last full tradingday prior to the announcement,each BP share was valued at$65.647. The transaction wasapproved by TP and BP's boardof directors and was subjectto customary closingconditions and BP shareholderapproval. Originally, TP wasrumored to be planning toacquire all the outstandingstock of BP.US - Teva Pharmaceutical Industries Ltd (TP) definitively agreed to acquire all the outstanding common stock of Barr Pharmaceuticals Inc (BP), a manufacturer, wholesaler and developer of generic and proprietary prescription pharmaceuticals, in a transaction valued at $8.81 bil. TP offered 0.6272 common shares and $39.90 in cash per TP share. Based on TP's closing stock price of July 17, the last full trading day prior to the announcement, each BP share was valued at $65.647. The transaction was approved by TP and BP's board of directors and was subject to customary closing conditions and BP shareholder approval. Originally, TP was rumored to be planning to acquire all the outstanding stock of BP.US - Teva Pharmaceutical Industries Ltd (TP) definitively agreed to acquire all theoutstanding common stock of Barr Pharmaceuticals Inc (BP), a manufacturer, wholesaler anddeveloper of generic and proprietary prescription pharmaceuticals, in a transaction valuedat $8.81 bil. TP offered 0.6272 common shares and $39.90 in cash per TP share. Based onTP's closing stock price of July 17, the last full trading day prior to the announcement,each BP share was valued at $65.647. The transaction was approved by TP and BP's board ofdirectors and was subject to customary closing conditions and BP shareholder approval.Originally, TP was rumored to be planning to acquire all the outstanding stock of BP.US - Teva Pharmaceutical Industries Ltd (TP) definitively agreed to acquire all the outstanding common stock of Barr Pharmaceuticals Inc (BP), a manufacturer, wholesaler and developer of generic andproprietary prescription pharmaceuticals, in a transaction valued at $8.81 bil. TP offered 0.6272 common shares and $39.90 in cash per TP share. Based on TP's closing stock price of July 17, the lastfull trading day prior to the announcement, each BP share was valued at $65.647. The transaction was approved by TP and BP's board of directors and was subject to customary closing conditions and BPshareholder approval. Originally, TP was rumored to be planning to acquire all the outstanding stock of BP.US - Teva Pharmaceutical Industries Ltd (TP) definitively agreed to acquire all the outstanding common stock of Barr Pharmaceuticals Inc(BP), a manufacturer, wholesaler and developer of generic and proprietary prescription pharmaceuticals, in a transaction valued at $8.81bil. TP offered 0.6272 common shares and $39.90 in cash per TP share. Based on TP's closing stock price of July 17, the last full tradingday prior to the announcement, each BP share was valued at $65.647. The transaction was approved by TP and BP's board of directors andwas subject to customary closing conditions and BP shareholder approval. Originally, TP was rumored to be planning to acquire all theoutstanding stock of BP.$ 8,847.214 - Lehman Brothers - Adv0.00000Lehman Brothers1.00000Banc of America Securities LLC1.00000$ 8,847.214 - Banc of America Securities LLC - Adv0.00000Pending52990.310007971.9090038421.9900089983.4010019.01400642.49700615.06500572.69700420.04700389.84000253.239002053.00000338.986001.310003.120002.030001.150001.620001.400002085.000001904.475001690.956001233.970001042.04600867.99500128.35000336.47700214.98800123.10300167.56600139.77800